Rising Dragon Acquisition Corp. - Unit (RDACU)
Community market perspectives and discussion for Rising Dragon Acquisition Corp. - Unit (NASDAQ: RDACU).
Community market perspectives and discussion for Rising Dragon Acquisition Corp. - Unit (NASDAQ: RDACU).
On our desk, we are watching the dramatic unwinding of RDAC's thin-float spring squeeze. After hitting highs above $21 in April, the stock has violently reversed, closing down 24.26% to $6.65 and sliding further by 10.58% to $6.00 following the Nasdaq delisting notice. Market sentiment has turned decidedly cautious as the speculative froth completely evaporates.
From a risk management standpoint, the August 19, 2026 Nasdaq compliance warning is a massive red flag. Falling below the minimum MVLS requirement gives them until February 16, 2027, to regain compliance by closing at or above $35 million. Given that the trust balance has dwindled to $18.37 million and redemptions have left only 1,685,982 ordinary shares subject to possible redemption, satisfying listing rules will be an uphill battle.
As a quant tracking SPAC capital structures, the latest 10-Q reveals a precarious balance sheet. Total assets stand at $18,426,287, with almost all of it tied up in the trust account ($18,370,925), leaving a meager $8,695 in cash outside the trust and a working capital deficit exceeding $1.32 million. Funding extension fees via unsecured promissory notes is keeping the lights on, but the financial runway is paper-thin.
Looking closely at the SEC filings, the massive wave of redemptions from the November 2025 vote onward completely gutted the shareholder base, shrinking the float and setting the stage for both the April spike and the subsequent vertical collapse. Analysts modeling post-merger dilution need to heavily discount the current valuation given the depleted $18.4M trust attempting to back a $350M stock consideration transaction.
As an options market maker, volume and participation metrics on RDACU are signaling extreme distress. Message chatter and unique account participation show heightened anxiety as retail holders exit post-redemption. With the merger deadline repeatedly pushed and structural capital deficits mounting, holding units through this delisting window carries binary downside risk.
Explore plasma cleansing, somatic organ swaps, and BCI.